Curia Global
Doreen Coull is a seasoned professional with over 20 years of experience in the Contract Development and Manufacturing Organization (CDMO) sector. Currently serving as Senior Director of Sales for Commercial Drug Product at Curia since June 2025, Doreen is responsible for promoting Drug Product Services across the UK and US. Prior to this role, Doreen held the position of Vice President of Business Development at BioCina, following the merger of BioCina and NovaCina and the launch of an integrated service offering. Doreen's career includes significant roles at NovaCina, Curia in two capacities, Aptuit, SCM Pharma, Eliesha Training Ltd, Coull Consulting, Bray Leino, and Covance Clinical Research Unit. Doreen’s educational background includes an MBA from the University of Exeter.
This person is not in any teams
This person is not in any offices
Curia Global
6 followers
With locations in North America, Europe and Asia, Curia’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in discovery, drug substance development, drug product formulation and process development, drug substance manufacturing, drug product manufacturing, and lab testing services.